Company: BIAF
Filing Date: 2025-05-30
Form Type: 8-K
Source: 0001641172-25-013021
Chunk: 1

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-30
Form: 8-K
Item: Item 3.01
Chunk 1
---
request would stay any suspension or delisting action pending the conclusion of the hearing process and the expiration of any additional
extension period granted by the panel following the hearing.

The
notification is separate from, and in addition to, the previously disclosed deficiency letter that the Company received from the Staff
on February 7, 2025 (the “ Minimum Bid Price Deficiency Letter”), with respect to the Company’s failure to maintain
a minimum closing bid price of $1.00 per share on any business day over a thirty consecutive business day period, as required for continued
listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “ Minimum Bid Price Requirement”).

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  bioAffinity                                          
  By:                     /s/                          
                          Maria                        
                          President                    

  Dated:        
  May 30, 2025  
 ────────────────